People · Operator
Named in public records as an officer, director or promoter · active 2014–2014 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pinteon Therapeutics, Inc. | — | Biotechnology | Series B | $39.2M | $603.8M | 2014 |
Kun Ping Lu at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kun Ping Lu on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jason Dinges | 1 | 8 |
| Stephanie O'Brien | 1 | 7 |
| Steven Kelly | 1 | 4 |
| Jeffrey L. Ives | 1 | 3 |
| Martin Jefson | 1 | 1 |
| Westley L. Nolin | 1 | 1 |
| Westley B. Nolin | 1 | 1 |
| Westley R. Nolin | 1 | 1 |
| Jason R. Dinges | 1 | 1 |
| Justin L. Burns | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.